TEVA PHARMACEUTICAL INDUSTRIES LTD - SPONSORED ADS (TEVA)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q1 2024
563 M
Holdings value Q1 2024
$7.94 B
Value change Q1 2024
-$17.4 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
456
Number of buys Q1 2024
230
Number of sells Q1 2024
-157
Average buys Q1 2024 %
+0.02%
Average sells Q1 2024 %
-0.005%
CUSIP
881624209
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 563 M $7.94 B -$17.4 M $14.11 456
2023 Q4 569 M $5.98 B +$223 M $10.44 427
2023 Q3 551 M $5.62 B +$724 M $10.20 419
2023 Q2 480 M $3.61 B -$709 M $7.53 407
2023 Q1 551 M $4.87 B -$28.5 M $8.85 418
2022 Q4 543 M $4.95 B +$2.42 M $9.12 398
2022 Q3 555 M $4.47 B +$430 M $8.07 380
2022 Q2 490 M $3.68 B -$46.3 M $7.52 408
2022 Q1 506 M $4.75 B +$104 M $9.39 411
2021 Q4 494 M $3.96 B -$264 M $8.01 390
2021 Q3 518 M $5.04 B -$346 M $9.74 405
2021 Q2 544 M $5.38 B -$134 M $9.90 419
2021 Q1 556 M $6.41 B +$15.1 M $11.54 426
2020 Q4 547 M $5.27 B +$54.4 M $9.65 409
2020 Q3 560 M $5.04 B -$193 M $9.01 411
2020 Q2 561 M $6.9 B +$316 M $12.33 426
2020 Q1 548 M $4.92 B -$448 M $8.98 422
2019 Q4 582 M $5.71 B -$12.6 M $9.80 397
2019 Q3 582 M $4 B -$352 M $6.88 381
2019 Q2 633 M $5.84 B -$327 M $9.23 430
2019 Q1 665 M $10.4 B -$208 M $15.68 489
2018 Q4 677 M $10.4 B +$639 M $15.42 517
2018 Q3 634 M $13.7 B -$673 M $21.54 550
2018 Q2 665 M $16.2 B +$160 M $24.32 532
2018 Q1 664 M $11.3 B +$1.3 B $17.09 499
2017 Q4 583 M $11 B +$1.03 B $18.95 500
2017 Q3 530 M $9.32 B -$1.11 B $17.60 520
2017 Q2 585 M $19.4 B +$410 M $33.22 647
2017 Q1 574 M $18.4 B +$209 M $32.09 681
2016 Q4 595 M $21.6 B +$595 M $36.25 725
2016 Q3 567 M $26.1 B -$1.24 B $46.01 784
2016 Q2 595 M $29.9 B -$270 M $50.23 810
2016 Q1 596 M $31.9 B -$699 M $53.51 828
2015 Q4 609 M $40 B +$4.9 B $65.64 864
2015 Q3 519 M $29.3 B +$629 M $56.46 805
2015 Q2 512 M $30.3 B -$367 M $59.10 808
2015 Q1 522 M $32.5 B +$494 M $62.30 821
2014 Q4 515 M $29.6 B +$654 M $57.51 813
2014 Q3 498 M $26.8 B +$670 M $53.75 762
2014 Q2 486 M $25.5 B +$774 M $52.42 778
2014 Q1 472 M $24.9 B +$989 M $52.84 768